Patent US5773293A successfully refreshed from Google Patents.
US5773293A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Anti-ICAM-4 antibodies and hybridomas
Assignee: Icos Corp
•
Filing: 1995-06-07
•
Granted: 1998-06-30
•
Expires: 2015-06-07
Abstract
Abstract DNA sequences encoding a novel intercellular adhesion molecule polypeptide (designated "ICAM-4") and variants thereof are disclosed along with methods and materials for production of the same by recombinant procedures. Antibody molecules that bind to ICAM-4, and uses thereof, are also disclosed.
Inventors
- 👤 Patrick D. Kilgannon
- 👤 W. Michael Gallatin
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-07 08:22
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/705; C07K14/70503; C07K14/70525; A; A01; A01K; A01K67/00; A01K67/027; A01K67/0271; C07K16/00; C07K16/18; C07K16/28; C07K16/2803; C07K16/2821; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/79; C12N15/85; C12N15/8509; C12Q; C12Q1/00; C12Q1/68; C12Q1/6876; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/68; G01N33/6893; G01N33/6896; A01K2207/00; A01K2207/15; A01K2217/00; A01K2217/05; A01K2267/00; A01K2267/01; A61; A61K; A61K38/00; A61K39/00; C07K2317/00; C07K2317/20; C07K2317/24; C07K2317/50; C07K2317/55; C07K2319/00; C07K2319/30; C12N2799/00; C12N2799/02; C12N2799/021; C12N2799/026
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
8 words
A hybridoma designated 127A (A.T.C.C. Accession Number HB11905).
Claim 2
Dependent Claim
8 words
A hybridoma designated 127A (A.T.C.C. Accession Number HB11905).
Claim 3
Dependent Claim
10 words
A monoclonal antibody secreted by the hybridoma of claim 1.
Claim 4
Dependent Claim
8 words
A hybridoma designated 127H (A.T.C.C. Accession. Number HB11911).
Claim 5
Dependent Claim
8 words
A hybridoma designated 127H (A.T.C.C. Accession. Number HB11911).
Claim 6
Dependent Claim
10 words
A monoclonal antibody secreted by the hybridoma of claim 3.
Claim 7
Dependent Claim
9 words
A hybridoma designated 173E (A.T.C.C. Accession Number HB 11912).
Claim 8
Dependent Claim
9 words
A hybridoma designated 173E (A.T.C.C. Accession Number HB 11912).
Claim 9
Dependent Claim
10 words
A monoclonal antibody secreted by the hybridoma of claim 5.
References Cited (Backward Citations)
WO1989002922A1
Cited
WO1990013300A1
Cited
WO1991010683A1
Cited
WO1991016928A1
Cited
EP0468257A1
Cited
WO1992004034A1
Cited
WO1992006199A2
Cited
WO1993014776A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-06-29 | 2001-12-29 | 2002-06-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-06-29 | 2005-12-29 | 2006-06-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-06-29 | 2009-12-29 | 2010-06-30 | $7700.00 | Window Closed / Lapsed |